Latest stories on SPRO
Spero Therapeutics Appoints Debra Jeske Zack, M.D., Ph.D., as Chief Medical Officer | SPRO Stock News
StockTitan56 · neutralproduct/pr
Spero Therapeutics: 'Buy' On Utebzi Royalty Deal For Funding And SP001 In-Licensing
Seeking Alpha63 · neutralanalyst
Spero gets ex-China rights to Innovent’s antibody therapy for up to $1.1B
Seeking Alpha73 · bullishm&a
At a glance: stocks gapping down premarket
Seeking Alpha38 · neutralgeneral
Spero Therapeutics Lands $105 Million Royalty Financing to Advance SP001 Development (SPRO)
InvestorsHub59 · neutralgeneral
Spero inks $105M financing deal with KKR affiliate
Seeking Alpha42 · neutralgeneral
Spero Therapeutics, Inc. (SPRO) files 8-K
SEC 8-K50 · neutralgeneral
Spero Therapeutics Expands Stock Incentive Plan and Authorization
TipRanks50 · neutralgeneral
Spero Therapeutics, Inc. (SPRO) files 8-K
SEC 8-K50 · neutralgeneral
Spero Therapeutics secures FDA approval for Utebzi
TipRanks88 · bullishproduct/pr
Spero Therapeutics, Inc. (SPRO) files 8-K
SEC 8-K50 · neutralgeneral
GSK, Spero Win FDA Nod For First-Ever Oral Carbapenem Antibiotic For Complicated UTIs
Yahoo Top73 · bullishproduct/pr
Spero Therapeutics: Yesterday's Selloff On Utebzi Approval Seems Bewildering
Seeking Alpha67 · bullishproduct/pr
Biggest stock movers Thursday: INTC, RUM, SPRO and more
Seeking Alpha50 · neutralgeneral
Utebzi (tebipenem pivoxil) approved in the US for adults with complicated urinary tract infections (cUTIs) | SPRO Stock News
StockTitan59 · neutralproduct/pr
GSK, Spero Therapeutics Gain U.S. Approval for Utebzi
Morningstar73 · bullishgeneral
Spero Therapeutics: Approval Upside, Commercial Friction (Initiating Hold)
Seeking Alpha51 · neutralanalyst